The most severe form of central plasma ophthalmopathy can cause irreversible damage to visual function, leading to permanent vision loss or even loss of vision, which seriously affects the patient’s quality of life. Central plasma ophthalmopathy, known as central plasma retinal chorioretinopathy, is a disease characterized by pathological changes such as fluid accumulation and vascular exudation in the macula. Some patients with monocular onset of the disease may recover on their own in 3 to 6 months, but active treatment is also required. Some patients have obvious symptoms and recurrent episodes that cannot be cured for a long period of time. If the disease is not treated in time, it can damage the vision and cause vision loss, which many times can lead to permanent vision loss or even blindness. Fundus laser photocoagulation (commonly known as playing laser) is currently a common treatment for middle plasma disease, with the aim of shortening the course of the disease. If the patient is suffering from MOP, it is recommended that he/she should go to the hospital for treatment in time to avoid delaying his/her condition and causing adverse effects on his/her eyesight.